|
🐜
|
Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
19 auth.
Nael H. Alami,
Rebecca B. Smith,
M. Carrasco,
Luis A. Williams,
C. Winborn,
Steve S. W. Han,
E. Kiskinis,
Brett J. Winborn,
Brian D. Freibaum,
A. Kanagaraj,
...
Alison J. Clare,
Nisha M. Badders,
B. Bilican,
E. Chaum,
S. Chandran,
C. Shaw,
K. Eggan,
T. Maniatis,
J. Paul Taylor
|
9 |
2014 |
9
🐜
|
|
🐜
|
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
13 auth.
S. Barmada,
Andrea Serio,
Arpana Arjun,
B. Bilican,
Aaron Daub,
Michael Ando,
Andrey S. Tsvetkov,
M. Pleiss,
Xingli Li,
D. Peisach,
...
C. Shaw,
S. Chandran,
S. Finkbeiner
|
8 |
2014 |
8
🐜
|
|
🦁
|
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
20 auth.
B. Bilican,
Andrea Serio,
S. Barmada,
A. Nishimura,
G. Sullivan,
M. Carrasco,
H. Phatnani,
C. Puddifoot,
David J. Story,
J. Fletcher,
...
In-Hyun Park,
Brad A. Friedman,
G. Daley,
D. Wyllie,
G. Hardingham,
I. Wilmut,
S. Finkbeiner,
T. Maniatis,
C. Shaw,
S. Chandran
|
8 |
2012 |
8
🦁
|
|
🐜
|
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy
18 auth.
Andrea Serio,
B. Bilican,
S. Barmada,
D. Ando,
Chenhao Zhao,
Rick Siller,
K. Burr,
Ghazal Haghi,
David J. Story,
A. Nishimura,
...
M. Carrasco,
H. Phatnani,
C. Shum,
I. Wilmut,
T. Maniatis,
C. Shaw,
S. Finkbeiner,
S. Chandran
|
8 |
2013 |
8
🐜
|
|
🐜
|
Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection.
14 auth.
Michael F. Wells,
M. Salick,
Ole Wiskow,
Daniel J. Ho,
Kathleen A. Worringer,
Robert J Ihry,
Sravya Kommineni,
B. Bilican,
Joseph R. Klim,
Ellen J Hill,
...
Liam T Kane,
Chaoyang Ye,
A. Kaykas,
K. Eggan
|
7 |
2016 |
7
🐜
|
|
🐜
|
Signaling Pathways Controlling Pluripotency and Early Cell Fate Decisions of Human Induced Pluripotent Stem Cells
11 auth.
L. Vallier,
T. Touboul,
S. Brown,
C. Cho,
B. Bilican,
Morgan Alexander,
...
J. Cedervall,
S. Chandran,
L. Ährlund‐Richter,
A. Weber,
R. Pedersen
|
7 |
2009 |
7
🐜
|
|
🐜
|
Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2
19 auth.
K. Bell,
Bashayer R. Al-Mubarak,
Marc‐André Martel,
S. Mckay,
Nicola Wheelan,
P. Hasel,
Nóra M. Márkus,
P. Baxter,
R. Deighton,
Andrea Serio,
...
B. Bilican,
S. Chowdhry,
P. Meakin,
M. Ashford,
D. Wyllie,
R. Scannevin,
S. Chandran,
J. Hayes,
G. Hardingham
|
7 |
2015 |
7
🐜
|
|
🐬
|
Cell-Mediated Neuroprotection in a Mouse Model of Human Tauopathy
D. Hampton,
D. J. Webber,
B. Bilican,
M. Goedert,
M. Spillantini,
S. Chandran
|
6 |
2010 |
6
🐬
|
|
🐜
|
Using human induced pluripotent stem cells to treat retinal disease
8 auth.
S. Borooah,
M. Phillips,
B. Bilican,
Alan F. Wright,
I. Wilmut,
S. Chandran,
...
D. Gamm,
Baljean Dhillon
|
6 |
2013 |
6
🐜
|
|
🦁
|
Induction of Olig2+ Precursors by FGF Involves BMP Signalling Blockade at the Smad Level
B. Bilican,
Christelle S Fiore-Heriche,
A. Compston,
N. Allen,
S. Chandran
|
5 |
2008 |
5
🦁
|
|
🐜
|
Ectopic Tbx2 expression results in polyploidy and cisplatin resistance
8 auth.
E. Davis,
Huajian Teng,
B. Bilican,
M. Parker,
B. Liu,
S. Carriera,
...
C. Goding,
S. Prince
|
5 |
2008 |
5
🐜
|
